Perez A, Murphy T
Hum Vaccin Immunother. 2017; 13(10):2322-2331.
PMID: 28853985
PMC: 5647992.
DOI: 10.1080/21645515.2017.1356951.
Murphy T, Brauer A, Johnson A, Wilding G, Koszelak-Rosenblum M, Malkowski M
Clin Vaccine Immunol. 2017; 24(9).
PMID: 28659326
PMC: 5585693.
DOI: 10.1128/CVI.00130-17.
Perez A, Murphy T
Vaccine. 2017; 37(37):5551-5558.
PMID: 28185742
PMC: 5545157.
DOI: 10.1016/j.vaccine.2016.12.066.
Ren D, E Pichichero M
Expert Opin Ther Targets. 2015; 20(1):19-33.
PMID: 26565427
PMC: 4720561.
DOI: 10.1517/14728222.2015.1081686.
Shaffer T, Balder R, Buskirk S, Hogan R, Lafontaine E
PLoS One. 2013; 8(7):e67881.
PMID: 23844117
PMC: 3699455.
DOI: 10.1371/journal.pone.0067881.
Comprehensive antigen screening identifies Moraxella catarrhalis proteins that induce protection in a mouse pulmonary clearance model.
Smidt M, Battig P, Verhaegh S, Niebisch A, Hanner M, Selak S
PLoS One. 2013; 8(5):e64422.
PMID: 23671716
PMC: 3650003.
DOI: 10.1371/journal.pone.0064422.
Epitope-specific immune recognition of the nontypeable Haemophilus influenzae outer membrane protein 26.
Kunthalert D, Novotny L, Massa H, Ulett G, Bakaletz L, Kyd J
Hum Vaccin Immunother. 2013; 9(3):625-35.
PMID: 23292125
PMC: 3891721.
DOI: 10.4161/hv.23255.
Mucosal immunization with the Moraxella Catarrhalis porin m35 induces enhanced bacterial clearance from the lung: a possible role for opsonophagocytosis.
Easton D, Cripps A, Foxwell A, Kyd J
Front Immunol. 2012; 2:13.
PMID: 22566804
PMC: 3341933.
DOI: 10.3389/fimmu.2011.00013.
Mutant lipooligosaccharide-based conjugate vaccine demonstrates a broad-spectrum effectiveness against Moraxella catarrhalis.
Ren D, Yu S, Gao S, Peng D, Petralia R, Muszynski A
Vaccine. 2011; 29(25):4210-7.
PMID: 21501641
PMC: 3109615.
DOI: 10.1016/j.vaccine.2011.03.102.
Characterization of proteins Msp22 and Msp75 as vaccine antigens of Moraxella catarrhalis.
Ruckdeschel E, Brauer A, Johnson A, Murphy T
Vaccine. 2009; 27(50):7065-72.
PMID: 19786139
PMC: 2783942.
DOI: 10.1016/j.vaccine.2009.09.062.
Mining the Moraxella catarrhalis genome: identification of potential vaccine antigens expressed during human infection.
Ruckdeschel E, Kirkham C, Lesse A, Hu Z, Murphy T
Infect Immun. 2008; 76(4):1599-607.
PMID: 18227159
PMC: 2292845.
DOI: 10.1128/IAI.01253-07.
Moraxella catarrhalis outer membrane protein CD elicits antibodies that inhibit CD binding to human mucin and enhance pulmonary clearance of M. catarrhalis in a mouse model.
Liu D, McMichael J, Baker S
Infect Immun. 2007; 75(6):2818-25.
PMID: 17403868
PMC: 1932855.
DOI: 10.1128/IAI.00074-07.
Intranasal vaccination with recombinant outer membrane protein CD and adamantylamide dipeptide as the mucosal adjuvant enhances pulmonary clearance of Moraxella catarrhalis in an experimental murine model.
Becker P, Bertot G, Souss D, Ebensen T, Guzman C, Grinstein S
Infect Immun. 2006; 75(4):1778-84.
PMID: 17101651
PMC: 1865668.
DOI: 10.1128/IAI.01081-06.
Identification and characterization of a novel outer membrane protein (OMP J) of Moraxella catarrhalis that exists in two major forms.
Hays J, van Selm S, Hoogenboezem T, Estevao S, Eadie K, van Veelen P
J Bacteriol. 2005; 187(23):7977-84.
PMID: 16291671
PMC: 1291255.
DOI: 10.1128/JB.187.23.7977-7984.2005.
Synthesis and characterization of lipooligosaccharide-based conjugate vaccines for serotype B Moraxella catarrhalis.
Yu S, Gu X
Infect Immun. 2005; 73(5):2790-6.
PMID: 15845482
PMC: 1087343.
DOI: 10.1128/IAI.73.5.2790-2796.2005.
The Moraxella catarrhalis porin-like outer membrane protein CD is an adhesin for human lung cells.
Holm M, Vanlerberg S, Foley I, Sledjeski D, Lafontaine E
Infect Immun. 2004; 72(4):1906-13.
PMID: 15039309
PMC: 375153.
DOI: 10.1128/IAI.72.4.1906-1913.2004.
The Moraxella catarrhalis immunoglobulin D-binding protein MID has conserved sequences and is regulated by a mechanism corresponding to phase variation.
Mollenkvist A, Nordstrom T, Hallden C, Christensen J, Forsgren A, Riesbeck K
J Bacteriol. 2003; 185(7):2285-95.
PMID: 12644500
PMC: 151486.
DOI: 10.1128/JB.185.7.2285-2295.2003.
Human immune response to outer membrane protein CD of Moraxella catarrhalis in adults with chronic obstructive pulmonary disease.
Murphy T, Kirkham C, Liu D, Sethi S
Infect Immun. 2003; 71(3):1288-94.
PMID: 12595444
PMC: 148877.
DOI: 10.1128/IAI.71.3.1288-1294.2003.
Specific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipooligosaccharide conjugate vaccine.
Jiao X, Hirano T, Hou Y, Gu X
Infect Immun. 2002; 70(11):5982-9.
PMID: 12379673
PMC: 130355.
DOI: 10.1128/IAI.70.11.5982-5989.2002.
Moraxella catarrhalis: from emerging to established pathogen.
Verduin C, Hol C, Fleer A, van Dijk H, van Belkum A
Clin Microbiol Rev. 2002; 15(1):125-44.
PMID: 11781271
PMC: 118065.
DOI: 10.1128/CMR.15.1.125-144.2002.